Myocardial PD-L1 Expression in Patients With Ischemic and Non-ischemic Heart Failure

Objective: Immune checkpoints inhibitors are promising and wide-spread agents in anti-cancer therapy. However, despite their efficacy, these agents could cause cardiotoxicity, a rare but life-threatening event. In addition, there are still no well-described predictive factors for the development of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kushnareva, Ekaterina, Kushnarev, Vladimir, Artemyeva, Anna, Mitrofanova, Lubov, Moiseeva, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792535/
https://www.ncbi.nlm.nih.gov/pubmed/35096992
http://dx.doi.org/10.3389/fcvm.2021.759972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792535/
https://www.ncbi.nlm.nih.gov/pubmed/35096992
http://dx.doi.org/10.3389/fcvm.2021.759972

Ejemplares similares